Navigation Links
Howard Dean to Join McKenna Long and Aldridge LLP
Date:3/3/2009

Chairman Emeritus of the DNC bolsters firm's national government affairs practice

WASHINGTON, March 3 /PRNewswire/ -- Governor Howard Dean -- a nationally recognized political figure, presidential candidate and six term Governor -- has agreed to serve as an independent consultant exclusive to the government affairs practice at McKenna Long & Aldridge LLP. Governor Dean will provide guidance to clients, particularly in the areas of healthcare and alternative energy resources.

Governor Dean joins MLA following his tenure as Chairman of the Democratic National Committee (DNC) where he created and implemented the "50 State Strategy." In his new role as Senior Strategic Advisor and Independent Consultant, he will use his experience running national campaigns to the benefit of states and municipalities. Governor Dean will leverage his position as a thought-leader on policy issues to the benefit of his clients in the health and energy sectors.

Respected for his fiscally moderate policies as Governor, he understands first-hand the severe budget constraints that are challenging state and municipal governments. His network of relationships across the U.S. complement the firm's strong presence nationally. He is uniquely positioned to develop partnerships between industry stakeholders and local governments.

Ambassador Gordon Giffin, who leads the firm's public policy department was enthusiastic about the addition of Governor Dean. "Our firm is honored that a man of Governor Dean's accomplishments and stature in the public policy arena has chosen to affiliate with us. His years of experience and thoughtful approach to public policy challenges will provide our clients with a remarkable resource as all businesses adjust to this era of government engagement with the private sector."

"After a long career in public office, I look forward to the opportunity to turn some attention to
'/>"/>

SOURCE McKenna Long and Aldridge LLP
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. Excerpts from DNC Chairman Howard Deans Remarks at the National Baptist Convention
2. Law Offices of Howard G. Smith Announces Class Action Lawsuit Against LCA-Vision Inc.
3. Law Offices of Howard G. Smith Announces Class Action Lawsuit Against Micrus Endovascular Corporation
4. UT Southwestern researcher named Howard Hughes Medical Institute investigator
5. CVS Caremarks Howard McLure Elected New PCMA Board Chairman
6. Law Offices of Howard G. Smith Announces Class Action Lawsuit Against WellCare Health Plans, Inc.
7. Law Offices of Howard G. Smith Announces 14 Days Remaining to Move to Be a Lead Plaintiff in the Shareholder Lawsuit Against Care Investment Trust Inc.
8. Law Offices of Howard G. Smith Announces 25 Days Remaining to Move to Be a Lead Plaintiff in the Shareholder Lawsuit Against Micrus Endovascular Corporation
9. Law Offices of Howard G. Smith Announces 25 Days Remaining to Move to Be a Lead Plaintiff in the Shareholder Lawsuit Against Threshold Pharmaceuticals, Inc.
10. Law Offices of Howard G. Smith Announces Class Action Lawsuit Against Security Capital Assurance Ltd.
11. Nektar Therapeutics President and CEO, Howard W. Robin, to Present at Merrill Lynch 19th Global Pharmaceutical, Biotechnology & Medical Device Conference in New York City
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2012)... CAMBRIDGE, Mass. (May 22, 2012) Pushed to the ... tumor tap into an ancient system that has helped ... life began. As an integral part of this ... to help malignant cells accommodate the genetic changes and ... , Researchers have theorized that inhibiting HSP90 just ...
(Date:5/22/2012)... Ore. Women who are unable to quit ... function of their newborns by taking Vitamin C ... Health & Science University Doernbecher Children,s Hospital. , ... the lung development of the developing baby, causing ... of asthma," said Cindy McEvoy, M.D., M.C.R., neonatologist ...
(Date:5/22/2012)... TUESDAY, May 22 (HealthDay News) -- The number of ... 2006, a new study finds. Researchers said one ... cardiac death has become more commonplace, and many of ... the organs aren,t healthy enough to attempt a transplant. ... due to a condition known as fatty liver disease, ...
(Date:5/22/2012)... engineers at UC Davis have developed a microfluidic chip ... will be cheaper, faster and more reliable than current ... reusable, and gives results in real time," said Ying ... in the UC Davis Department of Biomedical Engineering. , ... from patients in China and the United States. , ...
(Date:5/22/2012)... College of Wisconsin have identified novel biomarkers that could ... large groups of people potentially exposed to unknown and ... , The findings are published in the May 1 ... Baker, Ph.D., professor of surgery, biochemistry, pharmacology and toxicology ... author of the study. , There is an urgent ...
Breaking Medicine News(10 mins):Health News:Breast cancer clinical trial tests combo of heat shock protein inhibitor and hormonal therapy 2Health News:Breast cancer clinical trial tests combo of heat shock protein inhibitor and hormonal therapy 3Health News:Vitamin C improves lung function in newborns of pregnant smoking women 2Health News:U.S. Liver Transplants Declining 2Health News:New TB test promises to be cheap and fast 2
... against breast cancer on the road, JOHNS CREEK, ... to announce the launch of a unique yearlong breast ... Komen for the Cure.", Saia, a leading less-than-truckload ... designed to raise awareness about the disease,and the need ...
... Spans Four Levels of Care, ARLINGTON HEIGHTS, ... website where consumers can answer,a few questions and ... joint initiative of American Society of Plastic Surgeons ... (ASAPS)--is helping,consumers understand and make educated choices among ...
... small business to receive wellness discount, SOUTH ... and,Blue Shield, in partnership with the Maine State ... Publications of Brooklin is the first,small business in ... Chamber,BlueOptions. Woodenboat Publications will receive a 2 percent ...
... the Aspen,Institute has found gaps in the health care ... Barack Obama even as each of the,three offers thoughtful ... the United States., The Institute,s analysis is based ... and the principles that guided the,analysis were developed by ...
... arterial stiffening, enlarged hearts , , WEDNESDAY, May 14 (HealthDay ... may have health benefits, heavy drinking increases blood pressure, ... in men and enlarged hearts in women -- all ... , Men who drink more than 21 units of ...
... should permanently end use of Trasylol, experts say , , ... study confirms that people given Trasylol, a drug used ... of death by 53 percent. , Trasylol,s German maker, ... November after preliminary results from this trial revealed problems ...
Other Medicine News:Health News:Saia Partners with Susan G. Komen for the Cure 2Health News:Saia Partners with Susan G. Komen for the Cure 3Health News:A Range of Cosmetic Medicine Procedures For Any Age 2Health News:A Range of Cosmetic Medicine Procedures For Any Age 3Health News:Anthem Rewards Employers for Healthy Behaviors 2Health News:Presidential Candidates' Health Care Plans Lack Key Reform Elements, Aspen Institute Finds 2Health News:Presidential Candidates' Health Care Plans Lack Key Reform Elements, Aspen Institute Finds 3Health News:Presidential Candidates' Health Care Plans Lack Key Reform Elements, Aspen Institute Finds 4Health News:Excess Drinking Boosts Cardiovascular Disease Risk 2Health News:Danger From Heart Surgery Drug Confirmed 2Health News:Danger From Heart Surgery Drug Confirmed 3Health News:Danger From Heart Surgery Drug Confirmed 4
(Date:5/22/2012)... ThermoGenesis Corp. (NASDAQ: KOOL ), a leading ... administration of cell therapies, today said that it received ... (AXP) used for the processing of cord blood. The ... the country later this year. "We already ... market through our efforts in China, Malaysia and India, ...
(Date:5/22/2012)... 22, 2012  Comprehensive Care Corporation ("CompCare") (OTC ... and psychotropic pharmacy management services provider for managed ... its revenues for the first quarter of 2012 ... totaled $80,000 for the quarter. ... a profit, albeit modest, for its first quarter ...
(Date:5/22/2012)... 2012 Sorbent Therapeutics, Inc. a biopharmaceutical ... presented positive data from its Phase 2a clinical ... heart failure patients with chronic kidney disease, CLP1001 ... to placebo.    Data from the ... an oral session at the Annual European Society ...
Breaking Medicine Technology:ThermoGenesis Announces Axp Approval In Thailand 2ThermoGenesis Announces Axp Approval In Thailand 3Comprehensive Care Corporation Announces Profit for First Quarter 2Comprehensive Care Corporation Announces Profit for First Quarter 3Sorbent Therapeutics' CLP1001 Improves Heart Failure Symptoms In Phase 2 Clinical Study 2Sorbent Therapeutics' CLP1001 Improves Heart Failure Symptoms In Phase 2 Clinical Study 3MU veterinarians find infections faster by monitoring blood compound 22749 1How muscle fatigue originates in the head 87531 1How muscle fatigue originates in the head 87531 2Oxidative stress 3A Less harmful than suspected 3F 22747 1Oxidative stress 3A Less harmful than suspected 3F 22747 2
... 2007 - An evaluation of the,safety and effectiveness ... vaginal atrophy, a frequent complaint of,postmenopausal women, has ... (NAMS). Entitled "The role of local vaginal,estrogen for ... statement of The North American Menopause Society,",the document ...
... CORAL GABLES, Fla., May 09, 2007 /PRNewswire-FirstCall/ ... top-line results from a bioequivalence study demonstrating,that ... to Sabril Tablets, the version of vigabatrin ... potentially provide a basis,for linking CPP-109 to ...
Other Medicine Technology:New Position Statement from The North American Menopause Society,Addresses Use of Local Estrogen for Treatment of Vaginal Atrophy in,Postmenopausal Women 2New Position Statement from The North American Menopause Society,Addresses Use of Local Estrogen for Treatment of Vaginal Atrophy in,Postmenopausal Women 3Catalyst Pharmaceutical Partners, Inc. Announces Top-Line Results,of Its Bioequivalence Study of CPP-109 (Vigabatrin), the Company's,Investigational Drug to Treat Cocaine and Methamphetamine Addiction 2Catalyst Pharmaceutical Partners, Inc. Announces Top-Line Results,of Its Bioequivalence Study of CPP-109 (Vigabatrin), the Company's,Investigational Drug to Treat Cocaine and Methamphetamine Addiction 3Catalyst Pharmaceutical Partners, Inc. Announces Top-Line Results,of Its Bioequivalence Study of CPP-109 (Vigabatrin), the Company's,Investigational Drug to Treat Cocaine and Methamphetamine Addiction 4
... from Thermo Labsystems was designed specifically to ... features such as the new fast dial ... microvolumes help to define this as a ... new interchangeable handle plate offers a custom ...
Research® Series 2100 Adjustable-volume Pipette, 0.5-10 µl, single-channel with adjustable-volume setting...
This CLS number is a new product number, created to easily match Cornings product number. If showing no availability yet, please order under the old Sigma-Aldrich number (Z71,412-7) or contact custom...
... Series 2000 Pipette is a synonym for ... and robust design, and superior operating comfort. ... operate the measuring stroke and blow-out as ... features: Eppendorf "pipette/tip" system ensures utmost ...
Medicine Products: